8-KThe WireRoutine
Reg FD Disclosure · Company Update
Filed Oct 21, 2020 · 5y ago · Accession 0001564590-20-047025
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- CRISPR Therapeutics AG
- Ticker
- CRSP
- CIK
- 1674416
- Form type
- 8-K
- Filing date
- Oct 21, 2020
- Report date
- Oct 21, 2020
- Document
- crsp-8k_20201021.htm
- Size
- 5.4 MB